J. Scott Wolchko
2016
In 2016, J. Scott Wolchko earned a total compensation of $1.1M as President, Chief Executive Officer and Director at Fate Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $138,125 |
|---|---|
| Option Awards | $558,744 |
| Salary | $425,000 |
| Total | $1,121,869 |
Wolchko received $558.7K in option awards, accounting for 50% of the total pay in 2016.
Wolchko also received $138.1K in non-equity incentive plan and $425K in salary.
Rankings
In 2016, J. Scott Wolchko's compensation ranked 7,692nd out of 14,075 executives tracked by ExecPay. In other words, Wolchko earned more than 45.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,692 out of 14,075 | 45th |
Division Manufacturing | 2,915 out of 5,489 | 47th |
Major group Chemicals And Allied Products | 960 out of 1,895 | 49th |
Industry group Drugs | 744 out of 1,538 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 132 out of 279 | 53rd |
Source: SEC filing on March 22, 2017.
Wolchko's colleagues
We found two more compensation records of executives who worked with J. Scott Wolchko at Fate Therapeutics in 2016.